Wendy Vitek1, Fangbai Sun2, Kathleen M Hoeger3, Nanette Santoro4, Michael P Diamond5, Heping Zhang2, Richard S Legro6. 1. University of Rochester School of Medicine and Dentistry, Rochester, New York. Electronic address: wendy_vitek@urmc.rochester.edu. 2. Yale School of Public Health, New Haven, Connecticut. 3. University of Rochester School of Medicine and Dentistry, Rochester, New York. 4. University of Colorado School of Medicine, Aurora, Colorado. 5. Medical College of Georgia, Augusta University, Augusta, Georgia. 6. Penn State College of Medicine, Hershey, Pennsylvania.
Abstract
OBJECTIVE: To determine if short-term weight change among women with unexplained infertility (UI) and polycystic ovary syndrome (PCOS) undergoing ovulation induction is associated with live birth. DESIGN: Secondary analysis of randomized trials. SETTING: Multicenter fertility trial sites. PATIENT(S): A total of 900 women with UI and 750 women with PCOS. MAIN OUTCOME MEASURE(S): Live birth. INTERVENTION(S): Weight assessment at enrollment and start of up to 4-5 cycles of clomiphene, letrozole, or gonadotropins and intrauterine insemination for women with UI and clomiphene or letrozole with regular intercourse for women with PCOS. RESULT(S): Weight data were available for 856 women with UI and 697 women with PCOS. Mean weight change was -0.2 ± 0.3 kg among women with UI and +2.2 ± 0.2 kg among women with PCOS and did not differ based on treatment allocation. There were 115 women with PCOS (16.4%) who gained ≥3 kg. Increased body mass index and three or more cycles were associated with weight gain in women with PCOS. There was no difference in live birth rate among women with PCOS and ≥3 kg weight gain and women with PCOS who did not gain weight. CONCLUSION(S): Women with PCOS gained an average of 2.2 kg regardless of the medication received, whereas women with UI experienced no short-term weight change during ovulation induction. Weight gain in women with PCOS was not associated with live birth rate.
RCT Entities:
OBJECTIVE: To determine if short-term weight change among women with unexplained infertility (UI) and polycystic ovary syndrome (PCOS) undergoing ovulation induction is associated with live birth. DESIGN: Secondary analysis of randomized trials. SETTING: Multicenter fertility trial sites. PATIENT(S): A total of 900 women with UI and 750 women with PCOS. MAIN OUTCOME MEASURE(S): Live birth. INTERVENTION(S): Weight assessment at enrollment and start of up to 4-5 cycles of clomiphene, letrozole, or gonadotropins and intrauterine insemination for women with UI and clomiphene or letrozole with regular intercourse for women with PCOS. RESULT(S): Weight data were available for 856 women with UI and 697 women with PCOS. Mean weight change was -0.2 ± 0.3 kg among women with UI and +2.2 ± 0.2 kg among women with PCOS and did not differ based on treatment allocation. There were 115 women with PCOS (16.4%) who gained ≥3 kg. Increased body mass index and three or more cycles were associated with weight gain in women with PCOS. There was no difference in live birth rate among women with PCOS and ≥3 kg weight gain and women with PCOS who did not gain weight. CONCLUSION(S): Women with PCOS gained an average of 2.2 kg regardless of the medication received, whereas women with UI experienced no short-term weight change during ovulation induction. Weight gain in women with PCOS was not associated with live birth rate.
Authors: Nanette Santoro; Esther Eisenberg; J C Trussell; LaTasha B Craig; Clarisa Gracia; Hao Huang; Ruben Alvero; Peter Casson; Gregory Christman; Christos Coutifaris; Michael Diamond; Susan Jin; Richard S Legro; Randal D Robinson; William D Schlaff; Heping Zhang Journal: Hum Reprod Date: 2016-07-07 Impact factor: 6.918
Authors: Michael P Diamond; Richard S Legro; Christos Coutifaris; Ruben Alvero; Randal D Robinson; Peter Casson; Gregory M Christman; Joel Ager; Hao Huang; Karl R Hansen; Valerie Baker; Rebecca Usadi; Aimee Seungdamrong; G Wright Bates; R Mitchell Rosen; Daniel Haisenleder; Stephen A Krawetz; Kurt Barnhart; J C Trussell; Dana Ohl; Yufeng Jin; Nanette Santoro; Esther Eisenberg; Heping Zhang Journal: N Engl J Med Date: 2015-09-24 Impact factor: 91.245
Authors: Richard S Legro; William C Dodson; Allen R Kunselman; Christy M Stetter; Penny M Kris-Etherton; Nancy I Williams; Carol L Gnatuk; Stephanie J Estes; Kelly C Allison; David B Sarwer; Michael P Diamond; William D Schlaff; Peter R Casson; Gregory M Christman; Kurt T Barnhart; G Wright Bates; Rebecca Usadi; Scott Lucidi; Valerie Baker; Heping Zhang; Esther Eisenberg; Christos Coutifaris; Anuja Dokras Journal: J Clin Endocrinol Metab Date: 2016-05-12 Impact factor: 5.958
Authors: Susan Hutfless; Kimberly A Gudzune; Nisa Maruthur; Renee F Wilson; Sara N Bleich; Brandyn D Lau; Oluwakemi A Fawole; Cheryl A M Anderson; Jodi Segal Journal: Am J Prev Med Date: 2013-12 Impact factor: 5.043
Authors: Karl R Hansen; Amy Linnea W He; Aaron K Styer; Robert A Wild; Samantha Butts; Lawrence Engmann; Michael P Diamond; Richard S Legro; Christos Coutifaris; Ruben Alvero; Randal D Robinson; Peter Casson; Gregory M Christman; Hao Huang; Nanette Santoro; Esther Eisenberg; Heping Zhang Journal: Fertil Steril Date: 2016-03-03 Impact factor: 7.329
Authors: Audrey J Gaskins; Janet W Rich-Edwards; Daniela S Colaci; Myriam C Afeiche; Thomas L Toth; Matthew W Gillman; Stacey A Missmer; Jorge E Chavarro Journal: Obstet Gynecol Date: 2014-10 Impact factor: 7.661
Authors: Stefan Ghobrial; John Preston Parry; Iris Holzer; Judith Aschauer; Clara Selzer; Andreas Brezina; Samir Helmy-Bader; Johannes Ott Journal: J Clin Med Date: 2022-09-23 Impact factor: 4.964